Expression of proline-rich Akt-substrate PRAS40 in cell survival pathway and carcinogenesis1
- 1 October 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Pharmacologica Sinica
- Vol. 26 (10), 1253-1258
- https://doi.org/10.1111/j.1745-7254.2005.00184.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Neuroprotective Role of a Proline-Rich Akt Substrate in Apoptotic Neuronal Cell Death after Stroke: Relationships with Nerve Growth FactorJournal of Neuroscience, 2004
- United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signallingBiochemical Society Transactions, 2003
- Identification of a Proline-rich Akt Substrate as a 14-3-3 Binding PartnerJournal of Biological Chemistry, 2003
- New approaches to lung cancer preventionCurrent Oncology Reports, 2002
- Lung cancer * 1: Prevention of lung cancerThorax, 2002
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- Emerging therapies in non-small-cell lung cancerAnnals Of Oncology, 2001
- Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteinsProceedings of the National Academy of Sciences of the United States of America, 1999
- Recent Advances in Chemoprevention of CancerScience, 1997